Amylyx Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AMLX and other ETFs, options, and stocks.

About AMLX

Amylyx Pharmaceuticals, Inc. is a commercial-stage biotechnology company, which engages in the provision of therapies for neurodegenerative diseases and amyotrophic lateral sclerosis (ALS). Its commercial product is Relyvrio, also known as Albrioza in Canada. 

CEO
Joshua B. Cohen
CEOJoshua B. Cohen
Employees
384
Employees384
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2013
Founded2013
Employees
384
Employees384

AMLX Key Statistics

Market cap
127.43M
Market cap127.43M
Price-Earnings ratio
2.67
Price-Earnings ratio2.67
Dividend yield
—
Dividend yield—
Average volume
2.25M
Average volume2.25M
High today
$1.89
High today$1.89
Low today
$1.88
Low today$1.88
Open price
$1.97
Open price$1.97
Volume
4.32K
Volume4.32K
52 Week high
$30.50
52 Week high$30.50
52 Week low
$1.85
52 Week low$1.85

Analyst ratings

86%

of 7 ratings
Buy
14.3%
Hold
85.7%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.